FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

J Curtin

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Drug Resistance

Co-author Network

Publications

TOP 3
Amreen Husain; J Curtin; Carol L Brown; Dennis S Chi; William J Hoskins; Elizabeth A Poynor; Kaled M. Alektiar; Richard R Barakat
Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.
Paul Sabbatini; V Kudryashov; Govind Ragupathi; Samuel J Danishefsky; Philip O Livingston; William G Bornmann; Maria A Spassova; A Zatorski; David Spriggs; Carol Aghajanian; Steven L Soignet; M Peyton; Catherine O'Flaherty; J Curtin; Kenneth O Lloyd
Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.
Amreen Husain; Paul Sabbatini; David Spriggs; DW Fennelly; Carol Aghajanian; Richard R Barakat; J Curtin; Venkatraman E Seshan; William J Hoskins; Maurie Markman
Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of J Curtin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Amreen Husain; J Curtin; Carol L Brown; Dennis S Chi; William J Hoskins; Elizabeth A Poynor; Kaled M. Alektiar; Richard R Barakat
Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.
Gynecologic oncology 2000;78(2):208-11.
2000: Paul Sabbatini; V Kudryashov; Govind Ragupathi; Samuel J Danishefsky; Philip O Livingston; William G Bornmann; Maria A Spassova; A Zatorski; David Spriggs; Carol Aghajanian; Steven L Soignet; M Peyton; Catherine O'Flaherty; J Curtin; Kenneth O Lloyd
Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.
International journal of cancer. Journal international du cancer 2000;87(1):79-85.
1999: Amreen Husain; Paul Sabbatini; David Spriggs; DW Fennelly; Carol Aghajanian; Richard R Barakat; J Curtin; Venkatraman E Seshan; William J Hoskins; Maurie Markman
Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer.
Gynecologic oncology 1999;73(1):96-101.
1998: Carol Aghajanian; DW Fennelly; F Shapiro; RJ Waltzman; Lois Almadrones; Catherine O'Flaherty; K O'Conner; Venkatraman E Seshan; Richard R Barakat; J Curtin; Carol L Brown; Lilian Reich; David Wuest; Larry Norton; William J Hoskins; David Spriggs
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1852-60.
1997: Carol Aghajanian; Carol L Brown; Catherine O'Flaherty; A Fleischauer; J Curtin; R Roemeling; David Spriggs
Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer.
Gynecologic oncology 1997;67(2):127-30.
1996: Maurie Markman; T Hakes; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):796-9.
1995: DW Fennelly; J Schneider; David Spriggs; C Bengala; T Hakes; Lilian Reich; Richard R Barakat; J Curtin; Malcolm A S Moore; William J Hoskins
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1160-6.
1994: DW Fennelly; C Wasserheit; J Schneider; T Hakes; Lilian Reich; J Curtin; Tzy-Jyun Yao; M Markman; Larry Norton; John Crown
Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial.
Cancer research 1994;54(23):6137-42.
1994: Maurie Markman; P Francis; eric rowinsky; T Hakes; B Reichman; W Jones; J L Lewis; S Rubin; J Curtin; Richard R Barakat
Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 6():S55-8.
1993: B Reichman; Maurie Markman; T Hakes; S Rubin; W Jones; J Curtin; Richard R Barakat; Lois Almadrones; J L Lewis; William J Hoskins
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinoma.
Gynecologic oncology 1993;50(1):30-3.
1993: Maurie Markman; B Reichman; T Hakes; S Rubin; J L Lewis; W Jones; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
Gynecologic oncology 1993;50(1):100-4.
1993: Maurie Markman; J L Lewis; Patricia E Saigo; T Hakes; S Rubin; W Jones; B Reichman; J Curtin; Richard R Barakat; Lois Almadrones
Impact of age on survival of patients with ovarian cancer.
Gynecologic oncology 1993;49(2):236-9.
1993: Maurie Markman; T Hakes; B Reichman; S Rubin; J Curtin; Richard R Barakat; W Jones; J L Lewis; Lois Almadrones; William J Hoskins
Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: influence of increasing the volume of treatment.
Gynecologic oncology 1993;49(2):185-9.
1993: Maurie Markman; B Reichman; T Hakes; S Rubin; W Jones; J L Lewis; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
The use of recombinant human erythropoietin to prevent carboplatin-induced anemia.
Gynecologic oncology 1993;49(2):172-6.
1993: M Markman; B Reichman; T Hakes; J Curtin; W Jones; J L Lewis; Richard R Barakat; S Rubin; Borys Mychalczak; Patricia E Saigo
Intraperitoneal chemotherapy in the management of ovarian cancer.
Cancer 1993;71(4 Suppl):1565-70.
1993: Maurie Markman; D Alberts; S Rubin; T Hakes; J L Lewis; B Reichman; W Jones; J Curtin; Richard R Barakat; F Brodar
Evidence for persistence of mitoxantrone within the peritoneal cavity following intraperitoneal delivery.
Gynecologic oncology 1993;48(2):185-8.
1993: M Markman; J L Lewis; Patricia E Saigo; T Hakes; W Jones; S Rubin; B Reichman; Richard R Barakat; J Curtin; Lois Almadrones
Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience.
Cancer 1993;71(2 Suppl):634-7.
1993: Maurie Markman; L C DeMarco; M Birkhofer; D Budman; T Hakes; B Reichman; S Rubin; W Jones; Richard R Barakat; J Curtin
Phase II trial of zeniplatin (CL 286,558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy.
Journal of cancer research and clinical oncology 1993;119(4):234-6.
1993: P Francis; Maurie Markman; T Hakes; B Reichman; S Rubin; W Jones; J L Lewis; J Curtin; Richard R Barakat; M Phillips
Diethyldithiocarbamate chemoprotection of carboplatin--induced hematological toxicity.
Journal of cancer research and clinical oncology 1993;119(6):360-2.
1993: M Markman; eric rowinsky; T Hakes; B Reichman; W Jones; J L Lewis; S Rubin; J Curtin; Richard R Barakat; Lois Almadrones
Intraperitoneal administration of Taxol in the management of ovarian cancer.
Journal of the National Cancer Institute. Monographs 1993;(15):103-6.
1992: Maurie Markman; T Hakes; B Reichman; Richard R Barakat; J Curtin; W Jones; J L Lewis; S Rubin; Lois Almadrones; William J Hoskins
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
Seminars in oncology 1992;19(6 Suppl 14):25-7.
1992: Maurie Markman; B Reichman; T Hakes; S Rubin; W Jones; J L Lewis; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer.
Gynecologic oncology 1992;47(3):353-7.
1992: Maurie Markman; B Reichman; T Hakes; J L Lewis; W Jones; S Rubin; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1479-84.
1992: Maurie Markman; eric rowinsky; T Hakes; B Reichman; W Jones; J L Lewis; S Rubin; J Curtin; Richard R Barakat; M Phillips
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1485-91.
1992: Maurie Markman; W Jones; J L Lewis; S Rubin; T Hakes; B Reichman; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy.
Journal of cancer research and clinical oncology 1992;118(2):163-5.
1992: Maurie Markman; B Reichman; T Hakes; J Curtin; Richard R Barakat; S Rubin; W Jones; J L Lewis; Lois Almadrones; William J Hoskins
Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy.
Journal of cancer research and clinical oncology 1992;118(5):391-4.
1992: Maurie Markman; B Reichman; T Hakes; Richard R Barakat; J Curtin; S Rubin; W Jones; J L Lewis; Lois Almadrones; William J Hoskins
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate.
Journal of cancer research and clinical oncology 1992;118(3):235-7.
1992: Maurie Markman; T Hakes; B Reichman; J Curtin; Richard R Barakat; S Rubin; W Jones; J L Lewis; Lois Almadrones; William J Hoskins
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer.
Journal of cancer research and clinical oncology 1992;119(1):55-7.